Cancer biomarkers and mass spectrometry-based analyses of phospholipids in body fluids

Author： Jelonek Karol   Ros Malgorzata   Pietrowska Monika   Widlak Piotr  

Publisher： Future Medicine

ISSN： 1758-4299

Source： Clinical Lipidology, Vol.8, Iss.1, 2013-02, pp. : 137-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel TIA biomarkers identified by mass spectrometry‐based proteomics

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 8, 2015-12 ,pp. : 1204-1211

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mass spectrometry-based tissue proteomics for cancer biomarker discovery

By Balgley Brian M   Wang Weijie   De Voe Don L   Lee Cheng S  

Personalized Medicine, Vol. 4, Iss. 1, 2007-02 ,pp. : 45-58

Future Medicine

Access to resources Recommend Favorite

Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm

By Metzger Jochen   Luppa Peter B.   Good David M.   Mischak Harald  

Critical Reviews in Clinical Laboratory Sciences, Vol. 46, Iss. 3, 2009-06 ,pp. : 129-152

Informa Healthcare

Access to resources Recommend Favorite

What Have Mass Spectrometry-Based Proteomics and Metabolomics (Not) Taught Us about Psychiatric Disorders?

By  

Molecular Neuropsychiatry, Vol. 1, Iss. 2, 2015-05 ,pp. : 69-75

Karger

Access to resources Recommend Favorite

Mass spectrometry‐based proteomic analysis of formalin‐fixed paraffin‐embedded extrahepatic cholangiocarcinoma

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 9, 2015-09 ,pp. : 683-691

John Wiley & Sons Inc

Access to resources Recommend Favorite